Amedeo Smart

Free Medical Literature Service


 

Amedeo

Chronic Renal Failure

  Free Subscription

Articles published in
Nephron
    November 2017
  1. EL-HUSSEINI A, Wang K, Edon A, Saxon D, et al
    Value of Intraoperative Parathyroid Hormone Assay during Parathyroidectomy in Dialysis and Renal Transplant Patients with Secondary and Tertiary Hyperparathyroidism.
    Nephron. 2017 Nov 9. doi: 10.1159/000482016.
    >> Share

  2. AKRAWI DS, PirouziFard M, Fjellstedt E, Sundquist J, et al
    Heritability of End-Stage Renal Disease: A Swedish Adoption Study.
    Nephron. 2017 Nov 9. doi: 10.1159/000484327.
    >> Share

    October 2017
  3. POURAFSHAR N, Pourafshar S, Soleimani M
    Urine Ammonium, Metabolic Acidosis and Progression of Chronic Kidney Disease.
    Nephron. 2017 Oct 19. doi: 10.1159/000481892.
    >> Share

    September 2017
  4. YANG CW
    Leptospirosis Renal Disease: Emerging Culprit of Chronic Kidney Disease Unknown Etiology.
    Nephron. 2017 Sep 20. doi: 10.1159/000480691.
    >> Share

  5. VELOSO VSP, Ataides TL, Canziani MEF, Veloso MP, et al
    A Novel Missense GLA Mutation (p.G35V) Detected in Hemodialysis Screening Leads to Severe Systemic Manifestations of Fabry Disease in Men and Women.
    Nephron. 2017 Sep 12. doi: 10.1159/000479895.
    >> Share

    August 2017
  6. WONG SPY, O'Hare AM
    Making Sense of Prognostic Information About Maintenance Dialysis versus Conservative Care for Treatment of Advanced Kidney Disease.
    Nephron. 2017 Aug 26. doi: 10.1159/000479804.
    >> Share

    July 2017
  7. RATHORE AS, Chopra T, Ma JZ, Xin W, et al
    Long-Term Outcomes and Associated Risk Factors of Post-Hospitalization Dialysis-Dependent Acute Kidney Injury Patients.
    Nephron. 2017;137:105-112.
    >> Share

  8. TURGUT F, Abdel-Rahman EM
    Challenges Associated with Managing End-Stage Renal Disease in Extremely Morbid Obese Patients: Case Series and Literature Review.
    Nephron. 2017 Jul 28. doi: 10.1159/000479118.
    >> Share

  9. JIALAL I, Camacho F, Nathoo B, Tam P, et al
    Fibroblast Growth Factor 23 Predicts Mortality and End-Stage Renal Disease in a Canadian Asian Population with Chronic Kidney Disease.
    Nephron. 2017 Jul 26. doi: 10.1159/000479300.
    >> Share

    June 2017
  10. NG HY, Hsueh SK, Lee YT, Chiou TT, et al
    Synergic Impact of Vascular Calcification and Low Autonomic Tone in Mortality of Hemodialysis Patients.
    Nephron. 2017 Jun 22. doi: 10.1159/000477827.
    >> Share

  11. HUKRIEDE N, Vogt A, de Caestecker M
    Drug Discovery to Halt the Progression of Acute Kidney Injury to Chronic Kidney Disease: A Case for Phenotypic Drug Discovery in Acute Kidney Injury.
    Nephron. 2017 Jun 15. doi: 10.1159/000476079.
    >> Share

  12. FILHO AMS, Ventura CG, Criado PR, Del Negro GB, et al
    Hemodialysis and Kidney Transplantation as Predisposing Conditions to Onychomycosis.
    Nephron. 2017 Jun 14. doi: 10.1159/000475674.
    >> Share

  13. O HAINMHIRE E, Humphreys BD
    Fibrotic Changes Mediating Acute Kidney Injury to Chronic Kidney Disease Transition.
    Nephron. 2017 Jun 9. doi: 10.1159/000474960.
    >> Share

  14. NANGAKU M, Hirakawa Y, Mimura I, Inagi R, et al
    Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nephron. 2017 Jun 9. doi: 10.1159/000476078.
    >> Share

  15. SEKKARIE MA, Abdel-Rahman EM
    Cultural Challenges in the Care of Refugees with End-Stage Renal Disease: What Western Nephrologists Should Know.
    Nephron. 2017 Jun 8. doi: 10.1159/000477362.
    >> Share

  16. BROERS NJH, Martens RJH, Cornelis T, van der Sande FM, et al
    Physical Activity in End-Stage Renal Disease Patients: The Effects of Starting Dialysis in the First 6 Months after the Transition Period.
    Nephron. 2017 Jun 8. doi: 10.1159/000476072.
    >> Share

    May 2017
  17. WONGRAKPANICH S, Susantitaphong P, Isaranuwatchai S, Chenbhanich J, et al
    Dialysis Therapy and Conservative Management of Advanced Chronic Kidney Disease in the Elderly: A Systematic Review.
    Nephron. 2017 May 25. doi: 10.1159/000477361.
    >> Share

  18. SALEH T, Sumida K, Molnar MZ, Potukuchi PK, et al
    Effect of Age on the Association of Vascular Access Type with Mortality in a Cohort of Incident End-Stage Renal Disease Patients.
    Nephron. 2017 May 18. doi: 10.1159/000477271.
    >> Share

  19. BRITO JS, Borges NA, Esgalhado M, Magliano DC, et al
    Aryl Hydrocarbon Receptor Activation in Chronic Kidney Disease: Role of Uremic Toxins.
    Nephron. 2017 May 11. doi: 10.1159/000476074.
    >> Share

  20. GRANDJEAN-THOMSEN NL, Marley P, Shadbolt B, Farshid A, et al
    Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Nephron. 2017 May 6. doi: 10.1159/000473863.
    >> Share

  21. ALFANO G, Fontana F, Cappelli G
    Noninvasive Blood Pressure Measurement in Maintenance Hemodialysis Patients: Comparison of Agreement between Oscillometric and Finger-Cuff Methods.
    Nephron. 2017 May 4. doi: 10.1159/000457812.
    >> Share

    April 2017
  22. ARIF FM, Sumida K, Molnar MZ, Potukuchi PK, et al
    Early Mortality Associated with Inpatient versus Outpatient Hemodialysis Initiation in a Large Cohort of US Veterans with Incident End-Stage Renal Disease.
    Nephron. 2017 Apr 27. doi: 10.1159/000473704.
    >> Share

  23. BORJI R, Ahmadi SH, Barkhordari K, Meysami AP, et al
    Effect of Prophylactic Dialysis on Morbidity and Mortality in Non-Dialysis-Dependent Patients after Coronary Artery Bypass Grafting: A Pilot Study.
    Nephron. 2017;136.
    >> Share

  24. MUDI A, Ntsinjana H, Dickens C, Levy C, et al
    Cardiac Changes and Their Association with Fetuin-A and Fibroblast Growth Factor-23 in Children with Chronic Kidney Disease.
    Nephron. 2017 Apr 13. doi: 10.1159/000470858.
    >> Share

  25. MANSOURI L, Nopp A, Jacobson SH, Hylander B, et al
    Hemodialysis Patients Display a Declined Proportion of Th2 and Regulatory T Cells in Parallel with a High Interferon-gamma Profile.
    Nephron. 2017 Apr 6. doi: 10.1159/000471814.
    >> Share

    March 2017
  26. YAP N, Wong P, McGinn S, Nery ML, et al
    Femoral Neck X-Ray Absorptiometry Parameters and Peripheral Quantitative Computer Tomography Tibial Cortical Density Predict Survival in Dialysis Patients.
    Nephron. 2017 Mar 21. doi: 10.1159/000460262.
    >> Share

  27. OMOTOSO BA, Turgut F, Abdel-Rahman EM, Xin W, et al
    Dialysis Requirement and Long-Term Major Adverse Cardiovascular Events in Patients with Chronic Kidney Disease and Superimposed Acute Kidney Injury.
    Nephron. 2017 Mar 2. doi: 10.1159/000455749.
    >> Share

  28. NGUYEN HA, Anderson CA, Miracle CM, Rifkin DE, et al
    The Association between Depression, Perceived Health Status, and Quality of Life among Individuals with Chronic Kidney Disease: An Analysis of the National Health and Nutrition Examination Survey 2011-2012.
    Nephron. 2017 Mar 2. doi: 10.1159/000455750.
    >> Share

    February 2017
  29. PEREZ FONTAN M, Borras Sans M, Bajo Rubio MA, Rodriguez-Carmona A, et al
    Low Serum Levels of Vitamin D are Associated with Progression of Subclinical Atherosclerotic Vascular Disease in Peritoneal Dialysis Patients: A Prospective, Multicenter Study.
    Nephron. 2017 Feb 25. doi: 10.1159/000458418.
    >> Share

  30. YOUSSOUF S, Nache A, Wijesekara C, Middleton RJ, et al
    Effect of a Quality Improvement Program to Improve Guideline Adherence and Attainment of Clinical Standards in Dialysis Care: Report of Outcomes in Year 1.
    Nephron. 2017 Feb 25. doi: 10.1159/000450890.
    >> Share

  31. HOCHER B, Yin L
    Current Parathyroid Hormone Assays May Mislead Clinical Decision Making Particularly in Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.
    Nephron. 2017 Feb 10. doi: 10.1159/000455289.
    >> Share

  32. MOMOSE A, Shiraiwa Y, Narita S, Kusumi T, et al
    Total Calcium and Albumin Are Decreased in the Deeper Epidermis of Patients with Chronic Kidney Disease-Associated Pruritus.
    Nephron. 2017 Feb 10. doi: 10.1159/000458417.
    >> Share

  33. WALKER SR, Komenda P, Khojah S, Al-Tuwaijri W, et al
    Dipeptidyl Peptidase-4 Inhibitors in Chronic Kidney Disease: A Systematic Review of Randomized Clinical Trials.
    Nephron. 2017 Feb 9. doi: 10.1159/000454683.
    >> Share

  34. TYSON CC, Coffman TM
    In the Wake of Systolic Blood Pressure Intervention Trial: New Targets for Improving Hypertension Management in Chronic Kidney Disease?
    Nephron. 2017;135:287-290.
    >> Share

  35. GHOUTI-TERKI L, Chasseuil E, Rabot N, Paintaud G, et al
    Vancomycin during the Last Hour of the Hemodialysis Session: A Pharmacokinetic Analysis.
    Nephron. 2017 Feb 3. doi: 10.1159/000453005.
    >> Share

    January 2017
  36. GREEN D, Skeoch S, Alexander MY, Kalra PA, et al
    The Association of Baseline and Longitudinal Change in Endothelial Microparticle Count with Mortality in Chronic Kidney Disease.
    Nephron. 2017 Jan 25. doi: 10.1159/000452344.
    >> Share

  37. MOMOKI K, Yamaguchi T, Ohashi K, Ando M, et al
    Emergence of Dipstick Proteinuria Predicts Overt Nephropathy in Patients Following Stem Cell Transplantation.
    Nephron. 2017;135:31-38.
    >> Share


  38. UK Renal Registry 19th Annual Report: Appendix E Methodology for Estimating Catchment Populations of Renal Centres in the UK for Dialysis Patients.
    Nephron. 2017;137 Suppl 1:347-350.
    >> Share

  39. HOLE B, Caskey F, Evans K, Fluck R, et al
    UK Renal Registry 19th Annual Report: Chapter 12 Multisite Dialysis Access Audit in England, Northern Ireland and Wales in 2015 and 2014 PD One Year Follow-up: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:269-296.
    >> Share

  40. CROWLEY L, MacNeill S, Methven S, Nsonwu O, et al
    UK Renal Registry 19th Annual Report: Chapter 10 Epidemiology of Reported Infections in Patients Receiving Dialysis in England between January 2015 and December 2015: a Joint Report from Public Health England and the UK Renal Registry.
    Nephron. 2017;137 Suppl 1:251-258.
    >> Share

  41. METHVEN S, Perisanidou LI, Nicholas J, Dawnay A, et al
    UK Renal Registry 19th Annual Report: Chapter 8 Biochemical Variables amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:189-234.
    >> Share

  42. FORD D, Gilg J, Williams AJ
    UK Renal Registry 19th Annual Report: Chapter 7 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:165-188.
    >> Share

  43. HAMILTON AJ, Braddon F, Casula A, Lewis M, et al
    UK Renal Registry 19th Annual Report: Chapter 9 Clinical, Haematological and Biochemical Parameters in Patients on Renal Replacement Therapy in Paediatric Centres in the UK in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:235-250.
    >> Share

  44. METHVEN S, Steenkamp R, Fraser S
    UK Renal Registry 19th Annual Report: Chapter 5 Survival and Causes of Death in UK Adult Patients on Renal Replacement Therapy in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:117-150.
    >> Share

  45. HAMILTON AJ, Braddon F, Casula A, Lewis M, et al
    UK Renal Registry 19th Annual Report: Chapter 4 Demography of the UK Paediatric Renal Replacement Therapy Population in 2015.
    Nephron. 2017;137 Suppl 1:103-116.
    >> Share

  46. MACNEILL SJ, Ford D
    UK Renal Registry 19th Annual Report: Chapter 2 UK Renal Replacement Therapy Prevalence in 2015: National and Centre-specific Analyses.
    Nephron. 2017;137 Suppl 1:45-72.
    >> Share

    December 2016
  47. SEIBERT E, Muller SG, Pattmoller J, Kotanko P, et al
    Calf Resistivity Values in Chronic Kidney Disease in a Caucasian Population.
    Nephron. 2016.
    >> Share

  48. YAMAGUCHI J, Tanaka T, Inagi R
    Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy.
    Nephron. 2016.
    >> Share

  49. THAMRATNOPKOON S, Susantitaphong P, Tumkosit M, Katavetin P, et al
    Correlations of Plasma Desphosphorylated Uncarboxylated Matrix Gla Protein with Vascular Calcification and Vascular Stiffness in Chronic Kidney Disease.
    Nephron. 2016.
    >> Share

  50. CORTINOVIS M, Gotti E, Trillini M, Carrara F, et al
    Conversion from Brand-Name Neoral to the Generic Ciqorin in Stable Renal Transplant Recipients.
    Nephron. 2016.
    >> Share

    November 2016
  51. MUENDLEIN A, Ebner J, Zitt E
    Prevalence of the Janus Kinase 2 V617F Mutation in Patients with End-Stage Renal Disease.
    Nephron. 2016.
    >> Share

  52. WU B, Jiang H, He Q, Wang M, et al
    Liquid Chromatography/Mass Spectrometry Reveals the Effect of Lactobacillus Treatment on the Faecal Metabolite Profile of Rats with Chronic Renal Failure.
    Nephron. 2016.
    >> Share

  53. SANCHEZ V, Paniagua R, Prado MD, Mora C, et al
    High Prevalence of Diastolic Dysfunction in Incident Patients on Peritoneal Dialysis: Association with Low Thyroid Hormones.
    Nephron. 2016.
    >> Share

    October 2016
  54. CASTILLO-RODRIGUEZ E, Fernandez-Prado R, Martin-Cleary C, Pizarro-Sanchez MS, et al
    Kidney Injury Marker 1 and Neutrophil Gelatinase-Associated Lipocalin in Chronic Kidney Disease.
    Nephron. 2016.
    >> Share

  55. BORONAT M, Santana A, Bosch E, Lorenzo D, et al
    Relationship between Anemia and Serum Concentrations of Calcium and Phosphorus in Advanced Non-Dialysis-Dependent Chronic Kidney Disease.
    Nephron. 2016.
    >> Share

  56. RHEE CM, Kovesdy CP, Kalantar-Zadeh K
    Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data.
    Nephron. 2016.
    >> Share

  57. KIKUCHI M, Ueno M, Itoh Y, Suda W, et al
    Uremic Toxin-Producing Gut Microbiota in Rats with Chronic Kidney Disease.
    Nephron. 2016.
    >> Share

    August 2016
  58. SILVA CA, Barreto FC, Dos Reis MA, Moura Junior JA, et al
    Targeted Screening of Fabry Disease in Male Hemodialysis Patients in Brazil Highlights Importance of Family Screening.
    Nephron. 2016;134:221-230.
    >> Share

    July 2016
  59. ADEMA AY, de Jong MA, de Borst MH, Ter Wee PM, et al
    Phosphate Binding Therapy to Lower Serum Fibroblast-Growth-Factor-23 Concentrations in Chronic Kidney Disease: Rationale and Study Design of the Sevelamer on FGF23 Trial (SoFT).
    Nephron. 2016.
    >> Share

  60. YAMASAKI A, Yoda K, Koyama H, Yamada S, et al
    Association of Erythropoietin Resistance with Fatigue in Hemodialysis Patients: A Cross-Sectional Study.
    Nephron. 2016.
    >> Share

  61. TAKAORI K, Yanagita M
    Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
    Nephron. 2016.
    >> Share

  62. BOVIO G, Esposito C, Montagna G, Brazzo S, et al
    Inadequate Macronutrient and Micronutrient Intakes in Hemodialysis and Peritoneal Dialysis Patients: Data from a Seven-Day Weighed Dietary Record.
    Nephron. 2016;133.
    >> Share

  63. RENNIE TJ, Patton A, Dreischulte T, Bell S, et al
    Incidence and Outcomes of Acute Kidney Injury Requiring Renal Replacement Therapy: A Retrospective Cohort Study.
    Nephron. 2016.
    >> Share

  64. GURU PK, Singh TD, Akhoundi A, Kashani KB, et al
    Association of Thrombocytopenia and Mortality in Critically Ill Patients on Continuous Renal Replacement Therapy.
    Nephron. 2016;133:175-182.
    >> Share

  65. GILLIS KA, McComb C, Patel RK, Stevens KK, et al
    Non-Contrast Renal Magnetic Resonance Imaging to Assess Perfusion and Corticomedullary Differentiation in Health and Chronic Kidney Disease.
    Nephron. 2016.
    >> Share

    June 2016
  66. MALIK J, Lachmanova J, Kudlicka J, Rocinova K, et al
    Left Atrial Dysfunction in End-Stage Renal Disease Patients Treated by Hemodialysis.
    Nephron. 2016.
    >> Share

  67. DE VRIES EF, Rabelink TJ, van den Hout WB
    Modelling the Cost-Effectiveness of Delaying End-Stage Renal Disease.
    Nephron. 2016.
    >> Share

    April 2016
  68. MAJOR R, Shepherd D, Warwick G, Brunskill N, et al
    Prescription Rates of Cardiovascular Medications in a Large UK Primary Care Chronic Kidney Disease Cohort.
    Nephron. 2016.
    >> Share

    January 2016
  69. LINES SW, Richardson VR, Thomas B, Dunn EJ, et al
    Complement and Cardiovascular Disease--The Missing Link in Haemodialysis Patients.
    Nephron. 2016;132:5-14.
    >> Share

  70. FEEHALLY J, Coppo R, Troyanov S, Bellur SS, et al
    Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.
    Nephron. 2016;132:15-24.
    >> Share

  71. BAGCHI S, Agarwal S, Kalaivani M, Bhowmik D, et al
    Primary FSGS in Nephrotic Adults: Clinical Profile, Response to Immunosuppression and Outcome.
    Nephron. 2016;132:81-5.
    >> Share

  72. PRUTHI R, Casula A, MacPhee I
    UK Renal Registry 18th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2014: National and Centre-specific Analyses.
    Nephron. 2016;132 Suppl 1:69-98.
    >> Share

  73. DAVENPORT A, Shaw C, Steenkamp R
    UK Renal Registry 18th Annual Report: Chapter 7 Adequacy of Haemodialysis in UK Adult Patients in 2014: National and Centre-specific Analyses.
    Nephron. 2016;132 Suppl 1:155-68.
    >> Share

  74. AHMED A, Jorna T, Bhandari S
    Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
    Nephron. 2016;133:147-58.
    >> Share

  75. MADUELL F, Ojeda R, Arias-Guillen M, Rossi F, et al
    Eight-Year Experience with Nocturnal, Every-Other-Day, Online Haemodiafiltration.
    Nephron. 2016;133:98-110.
    >> Share

  76. WARNOCK DG
    Estimated Glomerular Filtration Rate: Fit for What Purpose?
    Nephron. 2016;134:43-9.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016